Gara Jalqabaatti › Dukkana Bladder › Ohio › Cincinnati
Qorannoo klinikaalii Dukkana Bladder Cincinnati, OH keessatti
Qorannoo 10 Dukkana Bladder f Cincinnati fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- fi 3 dabalataa
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Namoota walitti qabaa jiraSadarkaa 2
- TriState Urologic Services PSC Inc. dba The Urology Group ( Site 0122), Cincinnati
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Namoota walitti qabaa jiraSadarkaa 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · Miili 15 fagaatti
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Namoota walitti qabaa jiraSadarkaa 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · Miili 15 fagaatti
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Namoota walitti qabaa jiraSadarkaa 3
- TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0822), Cincinnati
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Namoota walitti qabaa jiraSadarkaa 3
- University of Cincinnati Medical Center, Cincinnati
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Namoota walitti qabaa jiraSadarkaa 2
- The Urology Group (Solaris), Cincinnati
- University of Cincinnati Cancer Center, Cincinnati
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Namoota walitti qabaa jiraSadarkaa 1
- University of Cincinnati Medical Center (UCMC), Cincinnati
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Cincinnati Medical Center, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Cincinnati
Qorannoo Dukkana Bladder magaalota biroo keessatti
- New York City, NYQorannoo 35
- Nashville, TNQorannoo 31
- Houston, TXQorannoo 31
- Dallas, TXQorannoo 27
- Boston, MAQorannoo 26
- Washington, DCQorannoo 26
- Los Angeles, CAQorannoo 24
- Baltimore, MDQorannoo 24
- St. Louis, MOQorannoo 22
- Philadelphia, PAQorannoo 21
- Seattle, WAQorannoo 21
- Edison, NJQorannoo 21
Qorannoo biroo Cincinnati keessatti
- Kansara Qara'a Non-Small CellQorannoo 35
- Saree (Gosoota Hunda)Qorannoo 27
- Saree OljooQorannoo 25
- Cufama OnneeQorannoo 24
- Kansarii ColorectalQorannoo 21
- Leukemia Myeloidii HamaaQorannoo 20
- Kansara MetastatikiiQorannoo 20
- Kansarii OvariiQorannoo 19
- Dhibee QaraQorannoo 19
- ObesityQorannoo 19
- Kansarii ProstateQorannoo 18
- Myeloma Baay’eeQorannoo 17
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.